RU2593984C1 - Drug administration device comprising signal feedback - Google Patents

Abstract

FIELD: medicine.

SUBSTANCE: invention relates to drug administration device and, in particular, to an improved, more convenient for user automatic drug administration device providing the user with audio, visual or tactile confirmation of injection. Drug administration device comprises a tubular body having a proximal end and an opposite distal end; driver device is made with possibility of action on the drug container to eject the medicinal agent; retaining appliance to retain said drive in the pre-tensed position; the activation unit configured to interact with said retainer to release said drive from the prestressed position; and a feedback unit configured to interact with said retainer and with said drive to generate an audial, and/or tactile, and/or visual signal indicating that the drug has been ejected completely. Activation unit represents a tubular activation element configured sliding and coaxial in relation to the tubular body. Holding device represents a tubular extension part rigidly fixed to the distal end of the tubular housing, and a tubular actuating element, which is connected to interact with tubular extension part and with the tubular actuating element. Said feedback device represents a longitudinally extending element that generates a signal, which represents an elongated U-shaped bracket containing a transverse wall and at least two longitudinally extending flexible arms equipped with inclined support elements extending radially outward. Said support elements are configured to rest on annular proximal end of tubular extension part when the drive is in the pre-tensed position.

EFFECT: invention is reliable and easy to use when handling and actuating.

15 cl, 11 dwg

Description

FIELD OF THE INVENTION

The present invention relates to a drug administration device and, in particular, to an improved, more user-friendly, automatic drug administration device providing the user with audible, tactile or visual confirmation of an injection.

BACKGROUND

Many drug administration devices for self-administration have been developed, that is, the user submits the drug to himself. This requires a drug administration device that is safe to use and as easy to handle as possible. To meet these requirements, the risk of errors related to the “human factor” must be minimized, the number of actions that must be performed to take the dose must be reduced, and the device must be intuitive and ergonomic to use. Thus, to minimize the risk of errors associated with the "human factor", you must have a device, if possible assembled in advance.

EP 1349590 B describes an injector having a number of features that facilitate the handling of the injector. Puncturing and injection is performed manually by simply pressing the proximal end of the needle protector at the injection site, causing the protector to move distally, allowing the needle to pierce the injection area and subsequently start the injection process. When the injection is completed, the injector is removed, as a result of which the needle protector retrieves the needle fixed to it.

Other aspects of the injectors relate to the person’s handling of the injector, namely, how the injector is held during operation, the main goal is to provide an ergonomic, patient-friendly injector that can pierce and inject into various parts of the body, for example near the waist, as well as the back of the waist, and / or in the buttocks of the patient. Sometimes the patient cannot see the injector in these positions and it is necessary to make it possible to hold the injector without changing the grip. When the action aimed at pressing a button and the like is eliminated, the patient can freely hold the device as he needs and feels comfortable. It is important for the patient to confirm that the injection was performed, in particular in cases where the injector is used, when the patient does not see the injector, for example, around the waist, as well as on the back of the waist and / or in the buttocks of the patient.

SUMMARY OF THE INVENTION

An object of the present invention is to provide a medication administration device that is reliable and easy to use when handling and actuating, which is achieved by a medication administration device comprising a driving agent configured to expose a medication container to expel a medication; holding means configured to hold said driving means in a prestressed state; activation means configured to interact with said holding means to release said driving means from a prestressed state; however, the device further comprises feedback means configured to interact with both said holding means and said driving means for generating an audible and / or tactile and / or visual signal indicating that the drug has been completely pushed out.

According to another aspect of the invention, the device further comprises a tubular body having a proximal end and an opposite distal end.

According to an additional aspect of the invention, the activation means is a tubular activating element that is slidably and coaxially arranged in the tubular body.

According to another aspect of the invention, the device further comprises a container holder coaxially placed in the tubular activating element and fixedly attached to the tubular body.

According to a still further aspect of the invention, the drug container is housed in said container holder and wherein said drug container contains a predetermined volume of drug, a movable stopper and an insertion element. According to another aspect of the invention, the drive means comprises a piston rod and a first resilient element which is prestressed and located in the piston rod, and wherein said piston rod is arranged so that it is in contact with the movable stopper in the drug container.

According to another aspect of the invention, the holding means is a tubular extension part fixedly connected to the distal end of the tubular body and the tubular actuating element, which is connected to interact with both the tubular extension part and the tubular activating element in such a way that when said tubular activating element pressed against the injection site, said tubular actuator rotates relative to said tubular extension Yelnia portion, whereby said actuating means is released from the prestressed state to exert pressure on the sliding stopper and thereby pushes the drug.

According to a further aspect of the invention, the feedback means is a longitudinally extending signal conditioning element coupled to interact with said tubular extension portion and said driving means so that when the piston rod is completely released from the tubular extension portion and a longitudinally extending signal conditioning element, longitudinally the passing signal conditioning element is released from said tubular extension portion and moves distally by the residual force of the first elastic element to form an audible, and / or tactile, and / or visual signal indicating that the drug is fully ejected.

According to a still further aspect of the invention, the tubular actuator comprises first matching means coupled to interact with a respective first matching means of the tubular activating element and a second matching means coupled to interacting with a corresponding second matching means of the tubular extension part; the piston rod comprises a releasable engaging means coupled to interact with the corresponding second matching means of the tubular extension, and the proximal end wall in contact with the movable limiter; a longitudinally extending signal forming element is arranged to be released on the inner surface of the tubular extension portion; and the first elastic element has a first end abutting against the proximal end wall of the piston rod, and a second end abutting against the transverse wall of the signal forming element.

According to another aspect of the invention, the second matching means comprises a groove on the inner surface of the tubular actuating element, and the corresponding second matching means of the tubular extension comprises an elastic tab having a protrusion directed radially inward.

According to another aspect of the invention, the releasing engagement means comprises a groove on the outer surface of the piston rod that engages releasably with a radially inwardly extending protrusion of the elastic tongue configured to hold the drive means in a prestressed state.

According to another additional aspect of the invention, the first matching means comprises a groove on the outer surface of the tubular actuating element, and the corresponding first matching means comprises a protrusion radially inward at the distal end of the inner surface of the tubular activating element, so that the protrusion protruding radially inward is configured to be guided into groove on the outer surface of the tubular actuator, prompting the tubular actuator lement rotated when the tubular actuating member is moved distally, the resilient tab is bent radially outwards in the groove on the inner surface of the tubular actuating member and extending radially inward projection is disengaged from the groove on the outer surface of the piston rod so that the drive means is released from the prestressed state.

According to another aspect of the invention, the signal-forming element is an elongated u-bracket containing a transverse wall and two longitudinally extending flexible arms provided with inclined support elements extending radially outward, and wherein said support elements are configured to rest on the annular proximal end of the tubular extension parts when the drive means is in a prestressed state.

According to a further aspect of the invention, the transverse wall of the U-bracket is located at a predetermined distance D from the inner distal surface of said tubular extension portion when the drive means is in a prestressed state.

According to yet another aspect of the invention, an audio signal is generated to confirm that the drug has been administered when the distal end of the piston rod has passed the support elements, so that longitudinally extending flexible shoulders with the support elements are released and can move radially inward, providing a U-shaped the bracket the ability to move a predetermined distance D in the distal direction by the residual force created by the aforementioned first elastic element, as a result of of lateral wall bracket hits the inner surface of the distal portion of said tubular extension.

According to a still further aspect of the invention, the transverse wall of the U-bracket comprises a distal protrusion and the distal surface of the tubular extension comprises a through hole, so that when the transverse wall of the U-bracket strikes the inner distal surface of said tubular extension, the distal protrusion passes through the through hole and protrudes in the distal direction for a predetermined distance above the outer surface of the said tubular tional part for generating a tactile signal.

According to another aspect of the invention, the distal protrusion has a bright color and / or a color different from the color of the rest of the device for generating a visual signal. The term “automatic drug administration device” as used herein refers to a drug administration device configured to administer a drug without the need for the user to press a push button or activating element, but only by pressing the proximal end of the drug administration device to the injection site.

In the automatic drug administration device, as mentioned above, it is considered important for the patient to obtain confirmation that the administration has been completed, in particular when the drug administration device is used in conditions where the patient does not see the drug administration device, for example around the waist, as well as on the back side of the waist and / or in the buttocks of the patient. Thus, a signal, namely, an audible sound, and / or a tactile signal, and / or a visual signal, or a combination thereof, is formed in direct temporary connection with the physical actuation of the drug container to expel the drug from the drug container.

The drug administration device of the present invention has many advantages. This is a high degree of functionality and automation that eliminates unnecessary components and actions for drug administration.

An important safety aspect is also observed, since when removed, the tubular activating element is pushed out and covers the insertion element, for example the needle, and is also fixed in the extended state, thus preventing the needle from being accidentally injected.

These and other aspects of the present invention and its advantages will become apparent from the following detailed description and from the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

In the following detailed description of the invention, reference will be made to the accompanying drawings, in which:

FIG. 1a-fig. 1c are perspective views of various components of a drug administration device.

FIG. 2a-fig. 2d are perspective views of various conditions of a drug administration device.

FIG. 3 - a block of a piston rod and an element for generating a sound-tactile-visual signal.

FIG. 4a-fig. 4c shows the components of a block from an element for generating a sound-tactile-visual signal and a piston rod.

FIG. 5 is a perspective view of the drive means of the present invention.

FIG. 6a - FIG. 6c is a side view of the tubular body and the sound-tactile-visual signal generating element during operation.

FIG. 7 - FIG. 11 is a side view along the longitudinal axis of a drug administration device according to an embodiment of the present invention, illustrating various states of an injection procedure.

DETAILED DESCRIPTION OF THE INVENTION

In this application, the term "distal part / end" refers to the part / end of the administration device or parts / ends of their elements, which / which are located farthest from the injection site of the drug in the patient. Accordingly, the term "proximal part / end" refers to the part / end of the administration device or parts / ends of its elements, which / which are located closest to the injection site of the drug in the patient.

In FIG. 1a is a perspective view of a tubular body 20 of an exemplary drug administration device 1. The tubular body 20 has a proximal end 11 and an opposite distal end 12. The tubular body 20 further comprises a protrusion (not shown) on its inner wall. The protrusion is configured to receive activation means, for example, a tubular activating element 30, in the recess 36 (see FIG. 1b). The recess 36 of the tubular activating element 30 is used to fix the tubular activating element 30 inside the tubular body 20 when the tubular activating element 30 is in its most proximal position after the injection. In an exemplary embodiment, there are two protrusions (not shown), one on each side of the inner wall of the tubular body 20, and accordingly, two recesses 36 of the tubular activating element 30. The tubular body 20 further comprises a container holder 50 located coaxially with the tubular body 20 and not moving attached thereto to accommodate the drug container 80 (see FIG. 1c). In an embodiment, the container holder 50 is arranged coaxially in the tubular activating element 30 and is fixedly attached to the tubular body 20. The drug delivery device 1 further comprises a tubular extension portion 22 located coaxially with the distal end 12 of the body and fixedly attached thereto, preferably by means of a flexible tongue 15, engaged with the corresponding protrusion 23 (see Fig. 5) of the tubular extension portion 22.

In FIG. 1b shows a tubular activating element 30 of a drug injection device 1. The tubular activating element 30 has an annular contact element 31 and a corresponding first matching means 35, which in an exemplary embodiment is a protrusion. In an exemplary embodiment of the invention, there are two corresponding first matching means 35 that are used to activate the drug administration device 1, as will be described in detail below. The drawing, in particular, illustrates the guide means 34, configured to interact with a corresponding guide rod (not shown) on the inner side of the tubular body 20, in order to prevent the tubular activating element 30 from rotating relative to the tubular body 20 and allow the tubular activating element 30 to move axially relative to the tubular body 20. In a preferred embodiment of the invention, there are two guide media Twa 34 and respectively two guide rods (not shown). According to an embodiment of the invention, the second elastic element 24 (see FIG. 1c), which in an exemplary embodiment is a tension spring located at the proximal end of the tubular activating element 30 to move it in the proximal direction. When the drug injection device 1 is in the final position, in order to prevent the proximal end of the needle 61 from being involuntarily accessible (see FIG. 1c), the notch / recess 36 engages with a corresponding protrusion (not shown) of the tubular body 20.

In FIG. 1c, the interior of the drug administration device 1 is further illustrated, further comprising a second elastic element 24 located relative to the tubular activating element 30 to move it in the proximal direction from the inactive position to the activated position, whereby the annular contact element 31 is in contact with the proximal end of the housing 20, when the drug injection device 1 is in an inactive state, and when the device 1 for injection of medicament is in the activated state, the annular contact element 31 located at a predetermined distance from the proximal end of the housing. The drug container 80 is located in the container holder 50 and has a predetermined volume of the drug, a movable stopper 83 and an insertion element. In an exemplary embodiment of the invention, the drug container 80 is a syringe equipped with a needle 61 as an administration element, but the invention is not limited to this, other embodiments may include a drug cartridge having a membrane 82, or the like, an insertion element may be adapted. The tubular actuator 100 (see FIG. 5) is also included in the drug delivery device 1, comprising a second matching means 101, 102 coupled to interact with a corresponding second matching means 35 of the tubular activating element 30 (see FIG. 1b), drive means comprising a piston rod 90 and a first elastic member 91 located in the piston rod. The piston rod comprises a releasable engagement / recessing means 94 (see FIG. 4c), interlocked with the corresponding second matching means 121 (see FIG. 5) of the tubular extension portion 22. In an exemplary embodiment of the invention, the first elastic member 91 is a tension spring. The proximal end 92 of the piston rod 90 is in contact with the movable stop 83. The tubular actuator 100 (see FIG. 5) is rotatable and coaxially located on the proximal portion of the tubular extension portion 22 between the container holder 50 and the annular protrusion of the tubular extension portion 22 at the distal end of the tubular body 20.

Together, the tubular extension portion 22 and the tubular actuator 100 form a holding means for holding the drive means in a prestressed state prior to piercing. When activating the activation means, the feedback means interacts with the holding means and the driving means to give a signal that the drug is completely pushed out.

In FIG. 2a - FIG. 2d are simplified perspective views of a drug administration device 1, with FIG. 2a illustrates the initial, inactive state of the drug administration device 1 having a cap 10. In FIG. 2b shows the activated state of the drug administration device 1 in which the cap 10 is removed. FIG. 2c shows the pricking and injection state of the drug administration device 1, and finally, FIG. 2d shows a drug administration device 1 in a final fixed state. In FIG. 2a, the drug administration device 1 comprises a tubular body 20 having a proximal end and an opposite distal end. The drug injection device 1 further comprises a tubular activating element 30 that is slidingly arranged coaxially in the tubular body 20 and includes a proximal annular contact element 31. The cap 10 comprises a distal end surface abutting against the surface of the proximal end of the annular tubular contact element 31 activating element 30 so that when the cap 10 is manually manipulated and disconnected, this ensures the movement of the tubular activating electric element 30 by means of a force from the second elastic element 24 (Fig. 1c) from an inactive position to an activated position.

In FIG. 2b shows a ready-to-use drug administration device 1. When the user is about to deliver a drug, for example, an injection, he presses the proximal end, namely, the annular contact element 31, to the injection site, namely, the injection site. The tubular activating element 30 then moves distally relative to the tubular body 20, and during relative movement, in the case where the drug delivery device acts as an injection device, the needle 61 manually punctures the skin. When the tubular activating element 30 is close to its most distal position relative to the tubular body 20, the drug is dispensed. The supply of the drug is performed automatically when the tubular activating element 30, in the activated position, moves distally relative to the tubular body 20, to the position for the introduction, in which the annular contact element 31 is located near the proximal end 11 of the tubular body 20.

In FIG. 2c, it is illustrated that when dispensing is performed, the user removes the drug delivery device 1 from the injection site, thereby moving the tubular activating element 30 in the proximal direction relative to the tubular body 20, by the force exerted by the second elastic element 24, and ultimately reaches the final condition; fixed state.

In FIG. 2d illustrates a drug administration device 1 in a final and fixed state in which the tubular activating element 30 is again at its maximum proximal position, as illustrated, in this state, the proximal part of the tubular activating element 30 completely protects the administration element 61 and the tubular activating element 30 also is fixed by cuts / recesses 36 (see Fig. 1b) at the distal end of the tubular activating element 30, engaging with protrusions (not illustrated ) Of the tubular body 20, in the final position, to prevent accidental introduction member 61 availability.

In FIG. 3 shows various aspects of a feedback means, for example, a signal conditioning element 110 and its embodiments (see also FIG. 4a - FIG. 4c). In FIG. 3 illustrates an embodiment of the invention comprising a signal generating element 110 configured to generate an audible, and / or tactile and / or visual injection confirmation signal in the case of drug administration, wherein the drug administration confirmation signal is generated when the driving means changes the position from the prestressed state, in which the first elastic element is prestressed and is located in the piston rod, and the piston rod adhered to the tubular extension part, to the released state, in which the piston rod is completely released from the tubular extension part and is no longer in contact with the signal forming element.

FIG. 4a - FIG. 4c are respectively side views and perspective views of a signal generating element 110 according to an exemplary embodiment of the invention. In the illustrated embodiment, the signal forming element 110 is an elongated u-shaped bracket having at least two elongated arms 111 extending in the proximal direction, a lower part, a distal transverse end wall 112 extending in the distal direction of the drug administration device, located in the tubular extension portion 22. The signal conditioning element 110 may be made of metal, plastic, or any combination of these materials.

In FIG. 4c is a perspective and partially exploded view of a signal generating element 110 with respect to the piston rod 90 and the first elastic element 91. The upper parts of the arms 111 are provided with inclined support elements 113 extending substantially radially outwardly with respect to the longitudinal axis of the U-bracket 110. U -shaped bracket 110 is configured to cover at least a portion of the piston rod 90 and the first elastic member 91, and the supporting members 113 are configured to abut the proximal th end of the tubular extension portion 22, when the drive means is in a pre-tensioned state, namely, the opening 94 of the piston rod 90 is engaged with the inwardly projecting lip 35 radially flexible tongue 121 of the tubular extension portion 22.

When the drive means is in a prestressed state, the distal end of the U-bracket 110 is located at a predetermined distance “D” (see FIG. 6a) from the inner distal surface of said tubular extension portion 22, and when the drive means is in the released state, the distal the end of the U-bracket 110 is in contact with the inner distal surface of said tubular extension portion 22. An audible and / or tactile and / or visual confirmation signal is generated when the distal the u-shaped end of the U-bracket 110 strikes the inner distal surface of the tubular extension portion 22 and is in contact with it under the influence of the residual force exerted by the first elastic member 91. Thus, during the feeding procedure, when the distal end of the piston rod 90 passes the supporting members 113, the shoulders 111 with support elements 113 are released and can be moved in a direction radially inward, due to the prestressing of the shoulders 111, allowing the u-bracket 110 to be moved in the distal direction and a signal is formed, usually a sound, and / or a visual signal, and / or a tactile signal, when the u-bracket 110 hits the distal end of the tubular extension portion 22. In the prestressed state, the u-bracket 110 is positioned so that the shoulders 111 located in space along the piston rod 90 between the piston rod 90 and the tubular extension portion 22 spanning the piston rod 90. The support elements 113 must have an expansion radially outward that exceeds the radial expansion of the space between the piston rod 90 and the inner wall of the tubular extension portion 22, to ensure that the signal conditioning element 110 is not released until the piston rod 90 offset back from a position between the shoulders 111. The outer distal surface of the distal transverse end wall 112 may further have a protrusion (not shown) configured to be guided through the opening, both clearly a through hole (also not shown) of the distal end wall of the tubular extension portion 22, and a distal predetermined distance extends above the outer surface of said tubular extension portion 22. In an exemplary embodiment of the invention, the distally protruding protrusion has a bright color and / or a color different from the rest devices for generating a visual signal. Thus, said protrusion can provide both a tactile and visual signal when the u-shaped bracket 110 hits the distal end of the tubular extension portion 22.

In FIG. 5 shows driving means as well as holding means, while the holding means comprises a tubular actuating element 100 and a tubular extension portion 22. The aforementioned first corresponding matching means 35 is at least one outward protrusion (see Fig. 1b) at the distal end the inner surface of the tubular activating element 30, and the first matching means is at least one groove 101, 102, 103 on the outer surface of the tubular actuating lementa 100 so that said exhaust radially inward projection 35 is arranged to be fed back to said at least one groove 101, 102, 103, causing the tubular actuating member 100 to rotate when the tubular actuating member 30 is moved axially. The second matching means 105 for holding the piston rod 90 and the first elastic element 91 in a prestressed state comprises at least one groove 105 of the tubular actuating element 100 and engages with a flexible tongue 121 on the tubular extension portion 22, which fixes the piston rod 90 by means of an outgoing radially into the protrusion 35 of the flexible tongue 121 and engages with the opening 94 of the piston rod 90. When the tubular actuator 100 rotates, at least one groove 105 of the tubular actuating element 100 allows radially extending the radially extending protrusion 35 of the flexible tongue 121, thereby releasing engagement between the protrusion 35 and the opening 94 of the piston rod 90, thereby releasing the rod 90 of the piston, which is affected by the force of the first elastic member 91, in the proximal direction.

The drug administration device 1 further comprises a fixing means coupled to interact with the tubular activating element 30. The fixing means is preferably at least one protrusion 106 on the annular surface of the tubular actuating element 100, and the corresponding second matching means is at least one the protrusion 95 on the outer surface of the tubular extension portion 22, so that the at least one protrusion 95 abuts against at least one protrusion 106, holding the tubular actuator 100 fixed rotatably to the tubular extension portion 22.

In FIG. 6a - FIG. 6c illustrates simplified side views of a distal portion of a drug administration device 1 according to the present invention. The purpose of these drawings is to briefly describe and illustrate the important elements required to achieve the set goals. The drawings show a tubular extension part 22, which partially covers the drive means, namely the piston rod 90 and the first elastic element 91, and the signal forming element 110.

In FIG. 6a, the drug administration device 1 is ready for use, wherein the signal generating element 110 is at a predetermined distance “D” from the inner distal surface of the tubular extension portion 22.

In FIG. 6b, the introduction procedure is started and the piston rod 90 moves in the proximal direction, causing the drug to be pushed out by a movable stopper 83 (not shown) through the insertion element 61. When the distal end of the piston rod 90 passes the proximal part of the signal conditioning element 110, the shoulders 111 of the signal forming element 110 are bent inward to move the signal forming element 110 in the distal direction, resulting in the formation of a sound and / or tactile signal and / or visual signal, when the signal conditioning element 110 is in contact with the inner distal surface of the tubular extension portion 22. This is shown in FIG. 6c.

In FIG. 7 - FIG. 11 shows side views along the longitudinal axis of the drug administration device 1. For the sake of simplicity, only elements related to the description of signal generation are indicated; in addition, in FIG. 7 - FIG. 11 shows some of the main parts of the drug administration device 1.

In FIG. 7 shows a drug administration device in an initial state in which a cap 10 is still attached to a drug administration device. The container 80 is located in a drug administration device having a predetermined volume of drug and also provided with an administration element 61 and a movable stop 83 at its distal end. The second elastic element 34 is placed at the proximal end of the drug administration device by exerting force on the tubular activating element 30 in the proximal direction. The piston rod 90 has a proximal end in contact with the movable limiter 83 and covering at least partially the first elastic member 91 configured to apply force to the piston rod 90 in the proximal direction. The distal portion of the piston rod 90 is housed in the tubular extension portion 22 in combination with the signal generating element 110. In the most distal part of the drug administration device 100, a distance “D” is indicated, namely, the distance of “sound generation” between the distal part of the signal forming element 110 and the inner distal surface of the tubular extension portion 22.

In FIG. 8 shows a drug administration device in a final fixed state in which the tubular activating element 30 is fixed in a proximal position, protecting the administration element 61.

In FIG. 9 shows a drug administration device in which the cap 10 is removed from the drug administration device, causing the tubular activating element 30 to move forward due to the forces created by the second elastic element 24. The drawing shows on a larger scale the proximal part of the signal forming element 110 and its supporting elements 113.

In FIG. 10 illustrates a drug delivery device in which the tubular activating element 30 is forced to move in the distal direction, causing the piston rod 90 to release to allow forces to be applied to the sliding stop 83, resulting in the delivery of the drug. The drawing shows on a larger scale the proximal part of the signal forming element 110 and its supporting elements 113, as well as the most distal part of the drug administration device.

In FIG. 11 illustrates a drug delivery device when the delivery is complete. The piston rod 90 now causes the sliding stopper 83 to eject all of the drug from the container 80 through the insertion member 61. When the distal part of the piston rod 90 passes the distal part of the signal conditioning element 110, the arms 111 will be able to move inward due to the prestressing of the arms (illustrated in the upper enlarged image) and the signal conditioning element 110 is released and thereby moves in the distal direction, forming a signal when it reaches the distal end surface of the tubular extension portion 22 (illustrated in the lower enlarged image).

Thus, a signal generating element 110 is provided, provided with two arms 111. As indicated above, a larger number of arms is naturally possible within the scope of the present invention limited by the appended claims, if a larger number of arms, for example, three or four, are assumed, it is important that all of them were prestressed so that they created radially directed forces inward, and also that they were evenly distributed in the plane of the cross section of the signal forming element 110, for n reliably hold the drive means in a pre-stressed state.

With reference mainly to FIG. 7-11, the operation of the drug administration device 1 will be described in more detail. In a prestressed state, at least one protrusion 95 abuts against the protrusion 106, and the groove 105 on the inner surface of the tubular activating element 30 blocks the flexible tongue 121, preventing the piston rod 90 from being released. When the cap 10 is removed, the drug administration device 1 is ready for use. The tubular activating element 30 is now in its most proximal position and the drug administration device 1 is ready for use. The tubular activating element 30 is forcibly moved by the user in the distal direction, and the protrusion 35 moves along the groove from position 101 to position 102, turning the tubular actuator 100 counterclockwise when viewed from the distal end. When the tubular actuator 100 is rotated, the protrusion 95 moves along the protrusion 106 and ultimately jumps off the protrusion 106, which can release the prestressed piston rod 90 to move in the proximal direction by the force exerted by the first elastic element 91 and apply forces to the sliding stop 83 , which is forcibly moved in the proximal direction and, therefore, the drug is supplied. When the drug is dispensed and the drug administration device is removed from the injection site, the tubular activating element 30 is forced to move in the proximal direction through the second elastic element 34 and the fixing means, for example, a flexible tongue 104 (see Fig. 5), at least one a groove of the tubular actuator 100, which blocks the protrusion 35 extending radially inward when the protrusion 35 radially extends over the tongue 104. The drug administration device 1 The device further comprises locking means coupled to interact with the tubular activating element 30. The locking means is a flexible tongue 104 on at least one groove of the tubular actuating element 100, which blocks the radially outward protrusion 35 when said radially inward protrusion 35 moves over tongue 104.

Signal conditioning is provided as follows. When the drive means is in a prestressed state, the distal end of the U-bracket 110 is located at a predetermined distance “D” (see FIG. 6a) from the inner distal surface of said tubular extension portion 22, and when the drive means is in a release state, the distal the end of the u-bracket 110 is in contact with the inner distal surface of said tubular extension portion 22. An audible, and / or tactile, and / or visual confirmation signal is generated when the dist The u-shaped end of the U-bracket 110 strikes and contacts the inner distal surface of the tubular extension portion 22 by the residual force created by said first elastic member 91. Thus, during the insertion procedure, when the distal end of the piston rod 90 passes the support members 113, the shoulders 111 with the supporting elements 113 are released and the possibility of their movement in the direction radially inward is provided, due to the prestressing of the arms 111, allowing the u-bracket 110 to be moved to the distal direction, and a signal is generated, usually an audible and / or visual signal, and / or a tactile signal, when the u-bracket 110 hits the distal end of the tubular extension portion 22. In the state before insertion, the u-bracket 110 is positioned so that shoulders 111 were located in space along the piston rod 90 between the piston rod 90 and the tubular extension portion 22 surrounding the piston rod 90. The support elements 113 must have an expansion radially outward that exceeds the radial expansion of the space between the piston rod 90 and the inner wall of the tubular extension portion 22 to ensure that the signal conditioning element 110 does not release before the piston rod 90 moves from the position between the arms 111. The outer distal surface of the distal transverse end wall 112 may further have a protrusion (not shown) configured to be directed through an opening, typically a well a bore hole (also not shown) of the distal end wall of the tubular extension portion 22, and extends a distally predetermined distance above the outer surface of said tubular extension portion 22. In an exemplary embodiment of the invention, the distal outgoing protrusion has a bright color and / or a color different from the color of the rest devices for generating a visual signal. Thus, said protrusion will be able to provide both a tactile and visual signal when the u-shaped bracket 110 hits the distal end of the tubular extension portion 22.

It should be understood that the embodiments described above and presented in the drawings should be considered only as non-limiting examples of the present invention, and can be modified within the scope of the attached claims.

Claims (15)

1. The device (1) the introduction of a medicinal product containing:
- a tubular body (20) having a proximal end (11) and an opposite distal end (12);
- a drive means configured to expose the drug container to eject the drug;
- holding means configured to hold said driving means in a prestressed state;
- activation means configured to interact with said holding means to release said driving means from a prestressed state, said activation means being a tubular activating element (30) slidably arranged and coaxial with respect to the tubular body (20);
moreover, the holding means is a tubular extension part (22) fixedly connected to the distal end of the tubular body (20), and a tubular actuating element (100), which is connected with the possibility of interaction with both the tubular extension part and the tubular activating element (30 );
- feedback means configured to interact with both said holding means and said driving means for generating an audible and / or tactile and / or visual signal indicating that the drug has been completely pushed out;
characterized in that said feedback means is a longitudinally extending signal forming element (110), which is an elongated U-shaped bracket containing a transverse wall (112) and at least two longitudinally extending flexible arms (111) provided with inclined support elements (113) extending radially outward, and said support elements (113) being able to rest on the annular proximal end of the tubular extension part (22) when the drive means is in redvaritelno stress. 2. The drug administration device (1) according to claim 1, wherein the device further comprises a container holder (50) placed coaxially in the tubular activating element (30) and fixedly attached to the tubular body (20). 3. The drug administration device (1) according to claim 2, wherein the drug container (80) is placed in said container holder (50), and wherein said drug container contains a predetermined volume of the drug, a movable stop (83 ) and the introduction element (61). 4. The drug administration device (1) according to claim 3, wherein the drive means comprises a piston rod (90) and a first elastic element (91) that is placed in a prestressed state in the piston rod and wherein said piston rod is placed that it is in contact with the sliding stop in the drug container. 5. The drug administration device (1) according to claim 4, wherein the tubular actuating element (100) is connected to interact with both the tubular extension part and the tubular activating element in such a way that when said tubular activating element is pressed into place of introduction, said tubular actuator rotates relative to said tubular extension part, as a result of which said drive means is released from a prestressed state I have to put pressure on the slide stop (83) and thereby pushing the drug. 6. The drug administration device (1) according to claim 5, wherein said longitudinally extending signal forming element (110) is coupled to interact with said tubular extension portion and with said drive means so that when the piston rod is completely released from the tubular of the extension portion and the longitudinally extending signal conditioning element, the longitudinally extending signal conditioning element is released from said tubular extension portion and moves distally beneath the action of the residual force of the first elastic element to form a sound, and / or tactile, and / or visual signal indicating that the drug is completely pushed out. 7. The drug administration device (1) according to claim 6, wherein said tubular actuator (100) comprises a second matching means (101, 102) coupled to interact with a corresponding second matching means (35) of the tubular activating element (30) ), and a second matching means (105), coupled with the possibility of interaction with the corresponding second matching means (121) of the tubular extension part (22); wherein the piston rod (90) comprises releasable engaging means (94) coupled to interact with the corresponding second matching means (121) of the tubular extension part (22) and the proximal end (92) of the piston rod (90) in contact with the movable limiter (83); moreover, a longitudinally extending signal forming element (110) is placed with the possibility of release on the inner surface of the tubular extension part (22); and the first elastic element (91) has a first end abutting against the proximal end wall of the piston rod (90), and a second end abutting against the transverse wall (112) of the signal forming element (110). 8. The drug administration device (1) according to claim 7, wherein the second matching means (105) comprises a groove on the inner surface of the tubular actuating element (100), and the corresponding second matching means (121) of the tubular extension part (22) contains an elastic a tongue having a protrusion directed radially inward. 9. The drug administration device (1) according to claim 8, wherein the releasing engagement means (94) comprises a recess on the outer surface of the piston rod (90), which is releasably engaged with a protrusion of an elastic tongue (121) made radially inward, made with the ability to hold the drive means in a prestressed state. 10. The drug administration device (1) according to claim 9, wherein the first matching means (101, 102) comprises a groove on the outer surface of the tubular actuating element (100), and the corresponding first matching means (35) comprises a protrusion extending radially inward on the distal end of the inner surface of the tubular activating element (30) in such a way that the protrusion radially inward (35) is made with the possibility of its direction in the groove (101, 102) on the outer surface of the tubular actuating element (100), waiting for the tubular actuator (100) to rotate when the tubular activating element (30) moves distally, as a result of which the elastic tab (121) bends radially outward into a groove (105) on the inner surface of the tubular actuator (100), and the protrusion extending radially inward disengages from the groove (94) on the outer surface of the piston rod (90) so that the drive means is released from the pre-stressed state. 11. The device (1) for the administration of a drug according to any one of paragraphs. 1-10, in which the transverse wall (112) of the U-bracket (110) is located at a predetermined distance D from the inner distal surface of said tubular extension portion (22) when the drive means is in a prestressed state. 12. The drug administration device (1) according to claim 11, wherein an audible signal is generated to confirm that the drug administration is performed when the distal end of the piston rod (90) has passed the support elements (113), so that the longitudinally extending flexible shoulders (111) with support elements (113) are released and can move in a radially inward direction, allowing the U-bracket (110) to move a predetermined distance D in the distal direction under the action of the residual force created by the aforementioned first elastic element (91), with the result that the transverse wall (112) of the bracket strikes the inner distal surface of said tubular extension part (22). 13. The drug administration device (1) according to claim 11, wherein the transverse wall (112) of the U-bracket (110) comprises a protrusion extending in the distal direction, and the distal surface of the tubular extension portion (22) comprises a through hole, thus that when the transverse wall (112) of the U-bracket (110) strikes the inner distal surface of the said tubular extension part (22), the distally extending protrusion passes through the through hole and protrudes distally to a predetermined distance above the outer surface aforementioned tubular extension portion (22) for generating a tactile signal. 14. The drug administration device (1) according to claim 12, wherein the transverse wall (112) of the U-bracket (110) comprises a protrusion extending in the distal direction and the distal surface of the tubular extension portion (22) comprises a through hole, thus that when the transverse wall (112) of the U-bracket (110) strikes the inner distal surface of the said tubular extension part (22), the distally extending protrusion passes through the through hole and protrudes distally to a predetermined distance above the outer surface aforementioned tubular extension portion (22) for generating a tactile signal. 15. The drug administration device (1) according to claim 13 or 14, wherein the distally extending protrusion has a bright color and / or a color different from the color of the rest of the device for generating a visual signal.

Images